Market Herald logo


Be the first with the news that moves the market

Canada’s main stock index rose higher on Monday on a broad increase, ahead of US inflation data due later in the week. Investors are eager for clues on the Federal Reserve’s monetary tightening strategy. Asian markets were down, while Euro markets were up.

Following its worst week since last December, US markets also moved upward as investors brace for more earnings reports from major-league companies. Treasury yields held steady, and energy prices were lower. The government will release monthly data on inflation in consumer prices on Tuesday.

Today in the Markets

TSX 20,702.23 +90.11 TSX
TSXV 616.41 +2.99 TSXV
CSE 193.50 -1.55 TSXV
DJIA 34,245.93 +376.66 DJIA
NASDAQ 12,502.31 +197.40 NASDAQ
S&P 500 4,131.04 +40.58 S&P 500

The Canadian dollar traded for 74.97 cents US, compared to 74.29 cents US on Friday.

US crude futures traded $0.36 lower at $97.36 a barrel, while the Brent contract lost $0.38 to $86.01 a barrel.

The price of gold was down US4.88 to US$1,858.13.

In world markets, the Nikkei was down 243.66 points to 27,427.32, the Hang Seng was down 26.00 points to 21,164.42, the FTSE was up 65.15 points to 7,947.60, and the DAX was up 89.36 points to 15,397.34.

Get @ the Bell delivered to your email inbox every day!

Sign Up Here

DISCLAIMER: By viewing any material on or distributed by The Market Herald Publishing Ltd. and its Information Providers you agree to both the following disclaimer, and the full disclaimer that can be viewed here.
Any holdings, theories, speculation or trades appearing anywhere on The Market Herald network of websites should not be relied upon for purposes of transacting securities or other investments, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. This applies to any material regardless of source, placement, presentation or reproduction. Any Information Providers to The Market Herald or employees of The Market Herald may from time to time have positions in the stocks or other entities mentioned anywhere on The Market Herald Network of websites. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. The Market Herald and its contributors makes no guarantee as to the validity of any information, speculation, theories or research presented herein whether pertaining to the past, present or future. The Service and The Materials are provided by The Market Herald and other Information Providers on an “as is” basis, and The Market Herald and other Information Providers expressly disclaim any and all warranties, express or implied, including, without limitation, warranties of satisfactory quality and fitness for a particular purpose, with respect to the service or any materials and products. In no event shall The Market Herald and other Information Providers be liable for any direct, indirect, incidental, punitive, or consequential damages of any kind whatsoever with respect to The Service, The Materials, and The Products.
More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.